Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination
- PMID: 19486574
Comparison of oral versus vaginal misoprostol for mid-trimester pregnancy termination
Abstract
Objective: To compare the efficacy and safety of oral versus vaginal administration of misoprostol for second trimester pregnancy termination.
Study design: Interventional, quasi experimental study.
Place and duration of study: The Department of Obstetrics and Gynaecology Unit-II, Fatima Jinnah Medical College/Sir Ganga Ram Hospital, Lahore, from August, 2003 to October, 2004.
Methodology: Sixty pregnant women at second trimester of gestation who were candidates for therapeutic termination of pregnancy were recruited for the study. Grandmultipara, women who had scarred uterus and history of hypersensitivity to prostaglandins were excluded. The subjects were assigned into two groups. Group 1 (n=30) had misoprostol orally, while the group 2 (n=30) received the drug by the vaginal route. Dosage regimen was similar in both groups that was 200 microg 4 hours apart till expulsion of fetus or maximum of upto 5 doses. Main outcome measures of the study were induction-expulsion interval, need for surgical evacuation and maternal complications.
Results: The mean induction-expulsion interval in the group 1 and 2 was 11.8+/-8.3 and 12.8+/-8.5 hours respectively, which was not different statistically. The process of expulsion was complete in 53.3% of subjects in both groups by misoprostol only, while 36.6% required surgical evacuation in oral group versus 33.3% in vaginal group. The rate of failed induction in groups 1 and 2 was 10% and 13.3% respectively. There was no reported case of nausea, diarrhea, headache, dizziness, shivering, pyrexia and hyperstimulation in both the groups. However, a case of vomiting (3.3%) was observed in the vaginal group.
Similar articles
-
Therapeutic termination of second trimester pregnancies with low dose misoprostol.J Coll Physicians Surg Pak. 2006 Jul;16(7):464-7. J Coll Physicians Surg Pak. 2006. PMID: 16827957
-
Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.Obstet Gynecol. 2004 Jul;104(1):138-45. doi: 10.1097/01.AOG.0000128947.31887.94. Obstet Gynecol. 2004. PMID: 15229013 Clinical Trial.
-
[Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].J Gynecol Obstet Biol Reprod (Paris). 2001 Sep;30(5):439-43. J Gynecol Obstet Biol Reprod (Paris). 2001. PMID: 11598557 Clinical Trial. French.
-
[Use of misoprostol for induction of labor in case of fetal death or termination of pregnancy during second or third trimester of pregnancy: Efficiency, dosage, route of administration, side effects, use in case of uterine scar].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):146-61. doi: 10.1016/j.jgyn.2013.11.008. Epub 2014 Jan 22. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24461423 Review. French.
-
Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks.Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S178-81. doi: 10.1016/j.ijgo.2007.09.007. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961566 Review.
Cited by
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD002253. doi: 10.1002/14651858.CD002253.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 Jun 17;6:CD002253. doi: 10.1002/14651858.CD002253.pub4. PMID: 16855990 Free PMC article. Updated.
-
Contraceptive utilization and pregnancy termination among female sex workers in Afghanistan.J Womens Health (Larchmt). 2010 Nov;19(11):2057-62. doi: 10.1089/jwh.2010.1947. Epub 2010 Sep 29. J Womens Health (Larchmt). 2010. PMID: 20879869 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
-
Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes.J Obstet Gynaecol India. 2015 Jul;65(4):246-50. doi: 10.1007/s13224-014-0587-3. Epub 2014 Jul 23. J Obstet Gynaecol India. 2015. PMID: 26243991 Free PMC article.
-
Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials